Drug details

Ortikos (budesonide extended-release capsules)

type of Corticosteroids

Ortikos (budesonide) is a corticosteroid indicated for treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon, in patients 8 years and older; and maintenance of clinical remission of mild to moderate Crohn's disease involving the ileum and/or the ascending colon for up to 3 months in adults.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• vomiting,
• easy bruising,
• lightheadedness,
• tiredness,
• weakness,
• pain or burning when you urinate,
• thinning skin,
• rectal bleeding,
• stretch marks,
• swelling in your ankles,
• increased acne or facial hair,
• menstrual problems (in women),
• impotence or loss of interest in sex (in men),
• increased body fat, and
• changes in the shape or location of body fat (especially in your face, neck, back, and waist)

The following drugs are related to Ortikos, either as a replacement or used together:

• Humira (adalimumab injection solution for subcutaneous administration)
• Azasan (azathioprine)
• Imuran (azathioprine)
• Entyvio (vedolizumab for injection, for intravenous use)
• Remicade (infliximab)
• Trexall (methotrexate)
• Tysabri (natalizumab)
• Stelara Injection (ustekinumab)